Avoidance of surgery for head and neck infantile myofibromatosis using imatinib monotherapy

Describe a novel use for a kinase inhibitor, imatinib, in young children with a known activated somatic mutation in PDGFR‐beta. Two patients with infantile myofibromatosis treated with imatinib. Case description of evaluation, diagnosis and treatment decisions for infantile myfibromatosis of the hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Pattisapu, Prasanth, Wenger, Tara L., Dahl, John P., Bly, Randall A., Bonilla‐Velez, Juliana, Wu, Natalie, Hall, Anurekha, Rudzinski, Erin R., Perkins, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826127/
https://www.ncbi.nlm.nih.gov/pubmed/35154723
http://dx.doi.org/10.1002/ccr3.5382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826127/
https://www.ncbi.nlm.nih.gov/pubmed/35154723
http://dx.doi.org/10.1002/ccr3.5382

Ejemplares similares